NCT07642531

Brief Summary

The research was designed as a randomized controlled study to determine the effectiveness of a modular cloud-based training platform in increasing awareness of fertility preservation. The study aims to develop a free, modular, cloud-based, sustainable digital platform to increase fertility awareness. The platform will provide basic information on fertility preservation methods in plain language to support informed decisions. Content will be based on European Society of Human Reproduction and Embryology (ESHRE) , International Federation of Gynaecology and Obstetrics (FIGO) and Asian Society of Gynecologic Oncology (ASCO) guidelines. The study targets not only cancer patients but also women requesting fertility preservation for medical or social reasons. In the first stage, the platform will be designed with the ADDIE instructional design model (Analysis, Design, Development, Implementation, Evaluation) and content created per international guidelines. In the second stage, the prototype will be pilot-tested and revised. In the third stage, effectiveness will be tested through a randomized controlled trial. Educational modules will be provided to the intervention group, while the control group will receive brochures. The study will include women aged 18-45 with early-stage gynecological cancer (cervix, ovary, tube, endometrium) at Prof. Dr. Cemil Tascioglu City Hospital, untreated. Participants must have Turkish literacy and internet access. Sample size, calculated with G\*Power, is 140 total (70 per group).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

September 2, 2026

Expected
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

June 12, 2026

Status Verified

June 1, 2026

Enrollment Period

4 months

First QC Date

June 8, 2026

Last Update Submit

June 11, 2026

Conditions

Keywords

fertilitygynecologic cancerfertility preservationmobile application

Outcome Measures

Primary Outcomes (4)

  • Awareness rates regarding fertility preservation options among patients in the experimental and control groups

    These data will be obtained through the answers given to the "Awareness status questionnaire for fertility protection".

    Change from beginning of the study and after 3 weeks of after the mobile application is given

  • fertility preservation knowledge scores

    The Fertility Health Knowledge Scale was developed to evaluate individuals' level of knowledge about fertility health; The Turkish validity and reliability study of the scale was conducted. In this study, the knowledge level of the participants regarding fertility/fertility preservation will be evaluated based on the knowledge score using the scale in question.

    Change from beginning of the study and after 3 weeks of after the mobile application is given

  • fertility preservation attitude scores

    The Attitudes Toward Fertility and Childbearing Scale was developed to evaluate the attitudes of women who have not yet become mothers towards fertility and childbearing. The Turkish validity and reliability study of the scale was conducted. In this study, participants' attitude scores (sub-dimensions and total attitude level) towards fertility and childbearing will be evaluated using the scale in question.

    Change from beginning of the study and after 3 weeks of after the mobile application is given

  • Acceptance of fertility preservation

    number of patients undergoing fertility preservation procedures

    Change from beginning of the study and after 3 weeks of after the mobile application is given

Study Arms (2)

Control- Routine information

NO INTERVENTION

The control group will be given an educational brochure with similar features for fertility preservation.

İntervention- Using the educational platform

EXPERIMENTAL

Prof. Dr. Cemil Taşçıoğlu City Hospital will divide female patients of reproductive age (18-45 years) who have been diagnosed with gynecological cancer (early-stage cervical, ovarian, tubal, and endometrial cancer) and have not yet started treatment, and who have been referred for egg/ovarian tissue/embryo freezing, into two groups. The intervention group will use the cloud-based sustainable education platform developed for fertility preservation within the scope of the study. The control group will be given an educational brochure with similar features for fertility preservation.

Other: Developing a Modular Cloud-Based Platform to guide decision-making in fertility preservation

Interventions

In this study, a modular cloud-based platform will be developed to raise awareness about fertility preservation.

İntervention- Using the educational platform

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women of reproductive age between the ages of 18 and 45,
  • Diagnosed with early stage cervical cancer, ovarian cancer, tubal cancer and endometrial cancer and whose treatment has not started,
  • Those who have a smartphone and can use the platform,
  • Volunteering and giving informed consent,
  • Turkish literate,
  • Individuals who do not report mental problems
  • Do not have children,
  • Marital status is married or single.

You may not qualify if:

  • Neurological disease (e.g., stroke, multiple sclerosis) or cognitive impairment,
  • Advanced-stage gynecologic cancers,
  • Failure to complete the follow-up period,
  • Initiation of oncologic treatment during the study period,
  • Non-completion or incomplete completion of the data collection instruments,
  • Non-use of the platform among participants allocated to the intervention group,
  • History of prior cancer treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biruni University

Istanbul, Zeytinburnu, 34020, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Fertility Preservation

Intervention Hierarchy (Ancestors)

Reproductive Techniques, AssistedReproductive TechniquesTherapeuticsTissue and Organ HarvestingTransplantationSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Nezihe KIZILKAYA BEJI, Professor

    Biruni University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nezihe KIZILKAYA BEJI, Professor

CONTACT

Huriye Sena Kuruc, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study will include women aged 18-45 with early-stage gynecological cancer (cervix, ovary, tube, endometrium) at Prof. Dr. Cemil Tascioglu City Hospital, untreated. Participants must have Turkish literacy and internet access. Sample size, calculated with G\*Power, is 140 total (70 per group). In study, In the intervention group (n = 70), the mobile application will be downloaded and demonstrated to the participants. In the control group (n = 70) will receive only a printed brochure containing the same content as the mobile application.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 8, 2026

First Posted

June 11, 2026

Study Start (Estimated)

September 2, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

June 12, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

The inverstigators did not obtain permission from the participants to share their data with other researchers.

Locations